For the primary endpoint, patients treated with povetacicept achieved a 52.0% reduction from baseline in proteinuria as measured by 24-hour urine protein to creatinine ratio (UPCR) and achieved a ...

Below is Validea's guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Multi-Factor Investor model based on the published strategy of ...

This project is a basic exploratory analysis of four facilities with Cost of Non-Conformance and Production data. This data is completely manufactured (fictonal) but many of the techniques that are ...

“LR, BD, SF, SG, and VM conceptualized and designed the study. LR collected and analyzed the data and wrote the original draft. BD, SF, VM, and SG reviewed and edited the manuscript. All authors ...

As passwords routinely fail to protect users, multi-factor authentication (MFA) is fast emerging as the new gold standard of cybersecurity. By adding extra layers of protection, MFA is able to block ...

Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H AI-powered HER2 quantification continuous score (QCS) and tumor ...

New biomarker analyses from the phase 3 KEYNOTE-522 trial provide insights into the biological factors that may influence response to pembrolizumab plus chemotherapy in early-stage triple-negative ...

Objectives The primary aim of this research is to uncover the underlying factors that shape hospital selection criteria among individuals in Lebanon. Design Cross-sectional study. Setting A survey was ...

ABSTRACT: To investigate scale development research in advertising, communication, and public relations, in this study, we analyzed 240 articles from 38 journals with a publication date up to 2023. We ...